GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] the ACHIEVE advice in here is 11 years out of date — 26 comments in the full submission. View in context.
360
c/orforglipron·submitted 1 year ago by u/sofia_petrescu

[Discussion] the ACHIEVE advice in here is 11 years out of date

Discussionbranch of 7 comments

Posting this because I searched for it and got nothing useful. Setup: 15mg, week 60, constipation present but not ruining anything. I changed exactly one variable — ATTAIN — and tracked it for 14 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted it. So I am…

Read the full submission and all 26 comments →

This branch

7 comments, started 1 year ago
u/phase_two_peteMOD14 points·1 year ago

Retitled to remove editorialising. Put the evidence in the body.

replysharereportpermalink
u/jonas_cardoso8 points·1 year ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/rasmus_petrescu0 points·1 year ago

the nausea profile is speculative at this stage

replysharereportpermalink
u/piotr_bruun1 point·1 year ago

Not to be pedantic but oral GLP-1 and small molecule are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/sofia_petrescuOP1 point·1 year ago

Not to be pedantic but oral GLP-1 and small molecule are being used interchangeably and they are not interchangeable in real life.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/sofia_petrescuOP1 point·1 year ago

the reflux profile is speculative at this stage

replysharereportpermalink
u/sofia_petrescuOP1 point·1 year ago

the absorption problem is solved by non-peptide structure

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.